Would you consider upadacitinib for GCA in a patient with history of breast cancer now in remission?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?

In a patient with recurrent episodes of GCA that flare shortly after steroid tapering, how do you differentiate between steroid-dependent inflammatory relapse, an alternative autoimmune vasculitic process, and a paraneoplastic phenomenon?

How would you approach an 80 year old patient with a history of pericardial effusion causing pericardial tamponade with peripheral eosinophilia, pANCA 1:1280 and MPO 139 but no other vasculitic phenomenon/renal dysfunction?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.